NEWS

LINNC online @ ALICE 2025: advancing through science and experience

INR stories: Saleh Lamin's uncensored interview

Treatment of recanalized pericallosal artery aneurysm

Day 1 @ ALICE 2025: live cases, innovation, and expert debates in neurointervention

Extended deadline: Submit your best WEB™ case before May 9!

Versatile coil used to treat a ruptured right A1-A2 junction aneurysm

Treatment of an unruptured PCOM aneurysm with a flow-diverter stent - Live Case

INR stories: Marc Ribo's uncensored interview

Q’Apel Medical Announces CE Mark Approval for Armadillo SelectFlex™ Neur...

Fremont, CA – January 13, 2025 – Q’Apel Medical (Q’Apel), a privately held medical device company focused on revolutionizing neurovascular interventions, today announced it has received CE mark certification for its Armadillo SelectFlex™ Neurovascular Access System. The first-of-its-kind 7F system features the patented SelectFlex™ Technology and is indicated for the introduction of interventional devices into the neurovasculature.  

Treatment of ruptured MCA aneurysm